Solugen — Startup Profile
Bio-based chemical manufacturing via a modular enzymatic platform
HQ: Houston, Texas, United States | Founded: 2016 | Employees: Unknown | Stage: Late Stage VC | Website: https://www.solugen.bio
About
Solugen has developed the Bioforge, a modular and reconfigurable bio-manufacturing platform that engineers enzymatic pathways to produce bio-based chemicals from sugar feedstocks rather than fossil fuels. Its first commercial product is Azogen, a low-carbon, fast-release fertilizer certified for organic farming. The company positions its platform as capable of producing genetically engineered substitutes for a range of petrochemicals used in everyday products.
The Take
Solugen operates a modular bio-manufacturing platform — the Bioforge — that uses engineered enzymatic pathways to produce bio-based chemicals intended to replace fossil-fuel-derived alternatives across agriculture and industrial applications.
Key Metrics
- Latest Valuation: $2B+
- Last Round: $200M+ Series D
- Total Funding: Not publicly aggregated
- Headcount: Not disclosed
- Founded: 2016
- Est. Runway: 560 months (modeled, unverified)
Funding Rounds
- Round: $30M (2021-01-21) — Existing investors (unspecified)
- Round: $200M+ (2022-11-02) — Undisclosed
- Round: $50M (2025-01-15) — Idealist Capital
- Round: $213.6M (2024-06-13) — U.S. Department of Energy, Loan Programs Office
Key People
- Gaurab Chakrabarti
- Sean Hunt
Key Competitors
- BASF —
- Ginkgo Bioworks —
- Yara International —
- Dow Inc. —
Timeline Highlights
- 2025-01-15: Azogen Equity Commitment
- 2024-06-13: DOE Loan Guarantee
- 2022-11-02: Series D
- 2021-01-21: Internal Round
- 2016: Company Founded
Recent News
- Solugen Secures Conditional Commitment for $213.6M DOE Loan Guarantee (2024-06-13)
- Solugen Raises $50 Million to Scale Production of Azogen Fertilizer (2025-01-15)
- Solugen Raises Over $200 Million Series D (2022-11-02)
- Houston's Solugen Wants to Make Greener Chemicals — and Profits (2022-10-28)
Similar Startups
- Benchling — Unified R&D Cloud for life sciences
- Altos Labs — Cellular rejuvenation programming to reverse disease and transform medicine
- Vilya — Computational biotech platform designing novel molecular structures to target disease biology
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- eGenesis — Genome engineering for human-compatible organ transplants
More Biotech & Life Sciences Startups
Category: Biotech & Life Sciences Startups
Browse: Home | Blog | About | All Startups A-Z | Biotech & Life Sciences Startups | View full profile on StartupWiki